Home » Posts tagged with » COVID-19
AstraZeneca resumes AZD1222 Covid-19 vaccine trials after brief pause

AstraZeneca resumes AZD1222 Covid-19 vaccine trials after brief pause

AstraZeneca said that clinical trials for the AZD1222 Covid-19 vaccine candidate, have resumed in various parts of the world after regulators across the US, UK, Brazil, Japan, and South Africa confirmed that it was safe to continue them. The US Food and Drug Administration (FDA) has authorized the restart of AZD1222 clinical trials in the […]

Covid-19 mRNA vaccine : Precision Nanosystems gets funding boost from Canadian govt

Precision Nanosystems (PNI) has received a funding boost of up to CAD 18.2 million from the Canadian government to develop a mRNA vaccine for Covid-19. The funding from Canada’s Innovation, Science and Economic Development’s (ISED) Strategic Innovation Fund (SIF) will help the Vancouver-based biotech company to move its Covid-19 mRNA vaccine candidate to clinical trials. […]

Continue reading …
Gilead Sciences bags Remdesivir FDA approval for Covid-19 treatment

Remdesivir FDA approval : Gilead Sciences, a California-based biopharma company, has bagged approval from the US Food and Drug Administration (FDA) for its antiviral drug Veklury (remdesivir) for Covid-19 treatment in patients requiring hospitalization. This makes remdesivir the first approved treatment for coronavirus in the US. Remdesivir FDA approved indication : Veklury has been approved […]

Continue reading …
Oxford develops rapid diagnostic test to detect Covid-19 within 5mins

Oxford University claimed that scientists from its Physics department have developed an extremely rapid diagnostic test for Covid-19. The rapid diagnostic test can detect and identify viruses within five minutes, said the UK-based university. The method can be used to differentiate the SARS-CoV-2 virus from negative clinical samples and also from other common respiratory pathogens […]

Continue reading …
AstraZeneca to advance AZD7442 into phase 3 Covid-19 trials

AstraZeneca said that AZD7442, which is being developed for the prevention and treatment of Covid-19, will move into two phase 3 clinical trials. AZD7442 is a combination of a couple of monoclonal antibodies (mAbs) extracted from convalescent patients with SARS-CoV-2 infection. It will be assessed in more than 6,000 participants at sites in and outside […]

Continue reading …
VirTrial to help BetterLife Pharma in launching COVID-19 clinical trials

VirTrial, a US bioscience technology company, has been selected by Canadian biotech company BetterLife Pharma as its telehealth platform provider of choice for launching COVID-19 clinical trials. The partnership will help BetterLife Pharma to carry out remote patient monitoring for its upcoming COVID-19 clinical trials in Australia for evaluating the efficacy of its interferon alpha 2b formulation […]

Continue reading …
EC strikes deal for supply of JNJ-78436735 Covid-19 vaccine candidate

Johnson & Johnson (J&J) said that the European Commission (EC) has approved an advance purchase agreement for securing 200 million doses of the JNJ-78436735 Covid-19 vaccine candidate (Ad26.COV2.S) developed by its subsidiary Janssen Pharmaceutical Companies. Currently, the JNJ-78436735 vaccine candidate is being evaluated in the phase 3 ENSEMBLE Covid-19 vaccine trial across certain countries. The […]

Continue reading …
Noxopharm doses first patient in NOXCOVID-1 clinical trial with Veyonda

Australian drug development company Noxopharm has dosed the first patient in the phase 1 NOXCOVID-1 clinical trial with Veyonda, its lead pipeline candidate, in hospitalized COVID-19 patients. Veyonda is an experimental anti-cancer drug. It is being evaluated in the NOXCOVID-1 clinical trial in the treatment of hospitalized patients with moderate lung dysfunction, who need low […]

Continue reading …
Novavax begins phase 3 trial of NVX-CoV2373 COVID-19 vaccine candidate

Novavax has initiated its first phase 3 clinical trial to assess the efficacy, safety, and immunogenicity of its NVX-CoV2373 COVID-19 vaccine candidate. The US vaccine development company is carrying out the late-stage trial in the UK in partnership with the UK government’s Vaccines Taskforce. The phase 3 trial of NVX-CoV2373 will aim to enroll and […]

Continue reading …
J&J begins phase 3 ENSEMBLE Covid-19 vaccine trial for JNJ-78436735

ENSEMBLE Covid-19 vaccine trial : Johnson & Johnson (J&J) has launched a multi-nation phase 3 trial called ENSEMBLE for its JNJ-78436735 Covid-19 vaccine candidate (Ad26.COV2.S), which is being developed by its subsidiary – Janssen Pharmaceutical Companies. The US healthcare giant said that the ENSEMBLE vaccine trial has been initiated following positive interim results from its […]

Continue reading …
Page 1 of 10123Next ›Last »